Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds.
Dietary ellagic acid and related polyphenols are metabolized in humans to dibenzopyran-6-one derivatives, and the microbial origin of these metabolites has been suggested. However, this has not been demonstrated so far. Fecal samples donated by six volunteers were incubated under anaerobic conditions, and aliquots were used to evaluate the fecal metabolism of ellagic acid, the ellagitannin punicalagin, and an ellagitannin rich extract from walnuts. The isoflavone daidzein was also incubated with the same fecal samples to follow the production of the microbial metabolites previously reported (dihydrogenistein, O-demethylangolensin, and equol) as a positive control of the system and to evaluate similarities between isoflavone and ellagic acid fecal flora metabolism. After fermentation the metabolite "urolithin A" (3,8-dihydroxy-6H-dibenzo[b,d]pyran-6-one) was produced from ellagic acid, punicalagin, and the ellagitannin extract in all the fecal cultures from different volunteers, but with very different production rates and concentrations. This large variability in the concentration of metabolite and kinetics of metabolite production is consistent with the large variability found in the excretion of these metabolites in urine in vivo after human consumption of ellagitannins, and with differences in the composition of the fecal microflora. No correlation between isoflavone and ellagic acid metabolism by fecal microflora was observed. The present study confirms the microbial origin of the recently reported in vivo generated hydroxy-6H-dibenzo[b,d]pyran-6-one derivatives in humans and is a further step in the study of the bioavailability and metabolism of ellagic acid and ellagitannins.
Research Group on Quality, Safety and Bioactivity of Plant Foods, Department of Food Science and Technology, CEBAS-CSIC, P.O. Box 164, 30100 Campus Universitario de Espinardo, Murcia, Spain.
Begoña
B
Cerdá
Paula
P
Periago
Juan Carlos
JC
Espín
Francisco A
FA
Tomás-Barberán
D001419:Bacteria / Q000378:metabolism*; D003106:Colon / Q000382:microbiology*; D003374:Coumarins / Q000378:metabolism*; D004032:Diet; D004610:Ellagic Acid / Q000008:administration & dosage / Q000378:metabolism* / Q000493:pharmacokinetics; D005243:Feces / Q000382:microbiology; D005285:Fermentation; D005419:Flavonoids / Q000008:administration & dosage / Q000378:metabolism; D006801:Humans; D047348:Hydrolyzable Tannins / Q000008:administration & dosage / Q000378:metabolism; D007529:Isoflavones / Q000378:metabolism; D010636:Phenols / Q000008:administration & dosage / Q000378:metabolism; D059808:Polyphenols
D003374:Coumarins; D005419:Flavonoids; D047348:Hydrolyzable Tannins; D007529:Isoflavones; D010636:Phenols; D059808:Polyphenols; C026423:3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one; D004610:Ellagic Acid